HER2 ICD DNA vaccine study featured on Good Morning America & ABC News
- Kiran Dhillon
- Nov 21, 2022
- 1 min read
We're excited to see the findings from our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD DNA vaccine in patients with advanced stage HER2+ breast cancer is being shared out through various media outlets. Check out the videos of the coverage by Good Morning America and ABC News.
Good Morning America: https://abcnews.go.com/GMA/Wellness/video/breast-cancer-vaccine-shows-promising-signs-preliminary-study-92655701
ABC News:
